Diagnosis and Management of Right-Sided Heart Failure in Subjects Supported With Left Ventricular Assist Devices

  • Matthew A. Romano
  • Jennifer Cowger
  • Keith D. Aaronson
  • Francis D. Pagani
Heart Failure

Opinion statement

Right ventricular failure (RVF) is a cause of major morbidity and mortality in the left ventricular assist device (LVAD) population. Many LVAD candidates have clinical or subclinical right ventricular (RV) dysfunction, and the perioperative period is fraught with insults that may provoke reactive pulmonary vascular hypertension and acute or chronic development of RVF. Thus, preoperative patient optimization using diuretics, pulmonary vasodilators, and inotropes to reduce RV wall stress and improve contractility is critical. An assessment of the LVAD candidate’s risk for developing postoperative RVF is also key, especially in the destination therapy population for whom good options for long-term RV support currently are lacking. Intraoperatively, various pharmacologic and surgical interventions are available to reduce RVF risk. This review discusses RVF diagnosis and management strategies in subjects undergoing LVAD implantation.

References and Recommended Reading

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Aaronson KD, et al.: Left ventricular assist device therapy improves utilization of donor hearts. J Am Coll Cardiol 2002, 39:1247–1254.CrossRefPubMedGoogle Scholar
  2. 2.
    Miller LW, et al.: Use of a continuous-flow device in patients awaiting heart transplantation. N Engl J Med 2007, 357:885–896.CrossRefPubMedGoogle Scholar
  3. 3.
    Rose EA, et al.: Long-term mechanical left ventricular assistance for end-stage heart failure. N Engl J Med 2001, 345:1435–1443.CrossRefPubMedGoogle Scholar
  4. 4.••
    Slaughter MS, et al.: Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009, 361:2241–2251.CrossRefPubMedGoogle Scholar
  5. 5.
    Dang NC, Topkara VK, Mercando M, et al.: Right heart failure after left ventricular assist device implantation in patients with chronic congestive heart failure. J Heart Lung Transplant 2006, 25:1–6.CrossRefPubMedGoogle Scholar
  6. 6.
    Deng MC, et al.: Mechanical Circulatory Support Device Database of the International Society for Heart and Lung Transplantation: Third Annual Report—2005. J Heart Lung Transplant 2005, 24:1182–1187.CrossRefPubMedGoogle Scholar
  7. 7.
    Fukamachi K, McCarthy PM, Smedira NG, et al.: Preoperative risk factors for right ventricular failure after implantable left ventricular assist device insertion. Ann Thorac Surg 1999, 68:2181–2184.CrossRefPubMedGoogle Scholar
  8. 8.
    Ochiai Y, et al.: Predictors of severe right ventricular failure after implantable left ventricular assist device insertion: analysis of 245 patients. Circulation 2002, 106(Suppl 1):198–202.Google Scholar
  9. 9.•
    Matthews JC, Koelling TM, Pagani FD, Aaronson KD: The right ventricular failure risk score a pre-operative tool for assessing the risk of right ventricular failure in left ventricular assist device candidates. J Am Coll Cardiol 2008, 51:2163–2172.CrossRefPubMedGoogle Scholar
  10. 10.
    Voelkel NF, Quaife RA, Leinwand LA, et al.: National Heart, Lung, and Blood Institute Working Group on Cellular and Molecular Mechanisms of Right Heart Failure: Right ventricular function and failure: report of a National Heart, Lung, and Blood Institute working group on cellular and molecular mechanisms of right heart failure. Circulation 2006, 114:1883–1891.CrossRefPubMedGoogle Scholar
  11. 11.
    Mebazaa A, et al.: Acute right ventricular failure—from pathophysiology to new treatments. Intensive Care Med 2004, 30:185–196.CrossRefPubMedGoogle Scholar
  12. 12.
    Kondo RP: Comparison of contraction and calcium handling between right and left ventricular myocytes from adult mouse heart: a role for repolarization waveform. J Physiol 2006, 571:131.CrossRefPubMedGoogle Scholar
  13. 13.
    Wang GY, McCloskey DT, Turcato S, et al.: Contrasting inotropic responses to alpha1-adrenergic receptor stimulation in left versus right ventricular myocardium. Am J Physiol Heart Circ Physiol 2006, 291:2013–2017.CrossRefGoogle Scholar
  14. 14.
    Kavarana MN, et al.: Right ventricular dysfunction and organ failure in left ventricular assist device recipients: a continuing problem. Ann Thorac Surg 2002, 73:745–750.CrossRefPubMedGoogle Scholar
  15. 15.
    Farrar DJ, Hill JD, Pennington DG, et al.: Preoperative and postoperative comparison of patients with univentricular and biventricular support with the thoratec ventricular assist device as a bridge to cardiac transplantation. J Thorac Cardiovasc Surg 1997, 113:202–209.CrossRefPubMedGoogle Scholar
  16. 16.
    Kormos RL, et al.: Transplant candidate’s clinical status rather than right ventricular function defines need for univentricular versus biventricular support. J Thorac Cardiovasc Surg 1996, 111:773–782.CrossRefPubMedGoogle Scholar
  17. 17.•
    Matthews JC, et al.: Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010, 121:214–220.CrossRefPubMedGoogle Scholar
  18. 18.
    The International Society of Heart and Lung Transplantation Annual Meeting and Scientific Sessions. Second INTERMACS Annual Report. Available at http://www.uab.edu/ctsresearch/intermacs/presentations.htm. Accessed March 31, 2010.
  19. 19.•
    Drakos SG, et al.: Risk factors predictive of right ventricular failure after left ventricular assist device implantation. Am J Cardiol 2010, 105:1030–1035.CrossRefPubMedGoogle Scholar
  20. 20.
    Morgan JA, John R, Lee BJ, et al.: Is severe right ventricular failure in left ventricular assist device recipients a risk factor for unsuccessful bridging to transplant and post-transplant mortality. Ann Thorac Surg 2004, 77:859–863.CrossRefPubMedGoogle Scholar
  21. 21.
    Sodha NR, Clements RT, Sellke FW: Vascular changes after cardiac surgery: role of NOS, COX, kinases, and growth factors. Front Biosci 2009, 14:689–698.CrossRefPubMedGoogle Scholar
  22. 22.
    Goldstein DJ, Beauford RB: Left ventricular assist devices and bleeding: adding insult to injury. Ann Thorac Surg 2003, 75(6 Suppl):S42–S47.CrossRefPubMedGoogle Scholar
  23. 23.
    Santambrogio L, Bianchi T, Fuardo M, et al.: Right ventricular failure after left ventricular assist device insertion: preoperative risk factors. Interact Cardiovasc Thorac Surg 2006, 5:379–382.CrossRefPubMedGoogle Scholar
  24. 24.•
    Fitzpatrick JR 3rd, et al.: Risk score derived from pre-operative data analysis predicts the need for biventricular mechanical circulatory support. J Heart Lung Transplant 2008, 27:1286–1292.CrossRefPubMedGoogle Scholar
  25. 25.
    Schenk S, et al.: Duration of inotropic support after left ventricular assist device implantation: risk factors and impact on outcome. J Thorac Cardiovasc Surg 2006, 131:447–454.CrossRefPubMedGoogle Scholar
  26. 26.
    Patel ND, et al.: Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices. Ann Thorac Surg 2008, 86:832–840.CrossRefPubMedGoogle Scholar
  27. 27.•
    Potapov EV, et al.: Tricuspid incompetence and geometry of the right ventricle as predictors of right ventricular function after implantation of a left ventricular assist device. J Heart Lung Transplant 2008, 27:1275–1281.CrossRefPubMedGoogle Scholar
  28. 28.•
    Puwanant S, et al.: Tricuspid annular motion as a predictor of severe right ventricular failure after left ventricular assist device implantation. J Heart Lung Transplant 2008, 27:1102–1107.CrossRefPubMedGoogle Scholar
  29. 29.
    Maeder MT, et al.: Changes in right ventricular function during continuous-low left ventricular assist device support. J Heart Lung Transplant 2009, 28:360–366.CrossRefPubMedGoogle Scholar
  30. 30.
    Rich S, et al.: The short-term effects of digoxin in patients with right ventricular dysfunction from pulmonary hypertension. Chest 1998, 114:787–792.CrossRefPubMedGoogle Scholar
  31. 31.
    Costard-Jackle A, Fowler MB: Influence of preoperative pulmonary artery pressure on mortality after heart-transplantation: testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high-risk group. J Am Coll Cardiol 1992, 19:48–54.CrossRefPubMedGoogle Scholar
  32. 32.
    Nakatani S, et al.: Prediction of right ventricular dysfunction after left ventricular assist device implantation. Circulation 1996, 94(Suppl):216–221.Google Scholar
  33. 33.
    Skhiri M, et al.: Evidence-based management of right heart failure: a systematic review of an empiric field. Rev Esp Cardiol 2010, 63:451–471.PubMedGoogle Scholar
  34. 34.
    Mullens W, et al.: Usefulness of isosorbide dinitrate and hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. Am J Cardiol 2009, 103:1113–1119.CrossRefPubMedGoogle Scholar
  35. 35.•
    Tedford RJ, et al.: PDE5A inhibitor treatment of persistent pulmonary hypertension after mechanical circulatory support. Circ Heart Fail 2008, 1:213–219.CrossRefPubMedGoogle Scholar
  36. 36.
    Argenziano M, et al.: Randomized, double-blind trial of inhaled nitric oxide in LVAD recipients with pulmonary hypertension. Ann Thorac Surg 1998, 65:340–345.CrossRefPubMedGoogle Scholar
  37. 37.
    De Wet CJ, et al.: Inhaled prostacyclin is safe, effective, and affordable in patients with pulmonary hypertension, right heart dysfunction, and refractory hypoxemia after cardiothoracic surgery. J Thorac Cardiovasc Surg 2004, 127:1058–1067.CrossRefPubMedGoogle Scholar
  38. 38.
    Wagner F, et al.: Nitric oxide inhalation in the treatment of right ventricular dysfunction following left ventricular assist device implantation. Circulation 1997, 96(Suppl):291–296.Google Scholar
  39. 39.
    Chang JC, et al.: Hemodynamic effect of inhaled nitric oxide in dilated cardiomyopathy patients on LVAD support. ASAIO J 1997, 43(5):418–421.CrossRefGoogle Scholar
  40. 40.
    Mertes PM, et al.: Impact of nitric oxide inhalation on right ventricular failure after implantation of Novacor left ventricular assist system. J Thorac Cardiovasc Surg 1995, 109:1251.CrossRefPubMedGoogle Scholar
  41. 41.
    Hare JM, et al.: Influence of inhaled nitric oxide on systemic flow and ventricular filling pressure in patients receiving mechanical circulatory assistance. Circulation 1997, 95:2250–2253.PubMedGoogle Scholar
  42. 42.
    Khan TA, et al.: A prospective, randomized, crossover pilot study of inhaled nitric oxide versus inhaled prostacyclin in heart transplant and lung transplant recipients. J Thorac Cardiovasc Surg 2009, 138:1417–1424.CrossRefPubMedGoogle Scholar
  43. 43.
    Mogollón Jiménez MV, et al.: Comparison between two drugs on the hemodynamic evaluation of pulmonary hypertension prior to heart transplantation. Transplant Proc 2008, 40:3009–3011.CrossRefPubMedGoogle Scholar
  44. 44.
    Arcangeli A, Rocca B, Salvatori G, et al.: Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter. Thromb Res 2010, 126:24–31.CrossRefPubMedGoogle Scholar
  45. 45.
    Catena E, Milazzo F: Echocardiography and cardiac assist devices. Minerva Cardioangiol 2007, 55:247–265.PubMedGoogle Scholar
  46. 46.
    Chumnavej S, Wood MJ, MacGillivary TE, Melo MF: Perioperative echocardiographic examination for ventricular assist device implantation. Anesth Analg 2007, 105:583–601.CrossRefGoogle Scholar
  47. 47.
    Agoustides JG: Perioperative echocardiographic assessment of left ventricular assist device implantation: additional causes of inflow cannula obstruction. Anesth Analg 2008, 106:673–674.CrossRefGoogle Scholar
  48. 48.
    Tector AJ, Kress DC, Downey FX, et al.: Transition from cardiopulmonary bypass to the HeartMate left ventricular assist device. Ann Thorac Surg 1998, 65:643–646.CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Matthew A. Romano
    • 1
  • Jennifer Cowger
    • 1
  • Keith D. Aaronson
    • 1
  • Francis D. Pagani
    • 1
  1. 1.University of Michigan Cardiovascular CenterAnn ArborUSA

Personalised recommendations